Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.7 |